Collects and assesses adverse-event information for marketed and investigational products, manages global safety-database data, supports regulatory compliance and inspections, and answers case-report queries.
Pfizer is a research-based global biopharmaceutical company that discovers, develops, manufactures, markets and sells biopharmaceutical products worldwide. Its prescription medicines are sold principally to wholesalers, and also directly to retailers, hospitals, clinics, government agencies and pharmacies, while its vaccines are sold largely to governments, wholesalers and providers.
Pfizer earns revenue from product sales, alliance arrangements with other drugmakers and royalties. Products named in its annual report include Eliquis, the Prevnar family, the Vyndaqel family, Comirnaty, Ibrance and Paxlovid. It recorded $62.6 billion in revenue in 2025, spent $10.4 billion on research and development, and employed about 75,000 people worldwide at year end.
- Can be worked in English
- 75%
- Remote or hybrid
- 50%
- Most requested
- Machine learning 1
- JLPT N1 3
- Native Japanese 2
- No Japanese level detected 9
- Japanese posting, level unstated 2
- Common areas
- Consulting & strategy 5
- Marketing 3
- Business development 2
- Data science 2
Measured from the 16 listings Ranked has live for Pfizer. Japanese level, visa signal and skills are AI-graded from each posting and can be wrong — confirm against the employer's original posting before applying.
16
open positions at Pfizer
4
Supports HR and employee-relations programs in Pfizer’s People Experience team, handling policies, HR operations, stakeholder coordination, and cross-functional projects with digital tools.
Leads vaccine medical affairs in Japan, identifying unmet needs, shaping medical plans, generating clinical evidence, and providing compliant scientific exchange with healthcare professionals.
Leads field medical affairs in dermatology, building scientific relationships with healthcare professionals, managing evidence activities, and supporting compliant medical strategy and product use.
Leads Japan’s Rare Disease commercial strategy, portfolio planning, launches, omnichannel engagement, and cross-functional teams for Pfizer’s Specialty Care organization.
Shapes Pfizer’s policy strategy in Japan by engaging policymakers and industry stakeholders, analyzing healthcare and legislative developments, and advising senior leaders.
Serves as Pfizer Japan’s medical-scientific contact for HCPs and external stakeholders, shaping medical plans, exchanging evidence, supporting studies, and ensuring compliant use of medicines.
Drive medical-affairs strategy for Pfizer’s lung-cancer portfolio, engaging healthcare professionals and societies, identifying unmet needs, supporting clinical development, and generating evidence.
Leads the amyloidosis medical affairs team in Japan, directing cardiology strategy, scientific exchange, evidence generation, stakeholder relationships, compliance, and people management.
Design, analyze, and interpret clinical trial and post-marketing surveillance data, providing statistical guidance for study plans, regulatory submissions, reports, and evidence generation.
This scientist supports Japan’s nonclinical drug-development and regulatory work, preparing submission documents, advising project teams, monitoring global studies, and shaping local development strategy.
Lead medical and scientific oversight for vaccine clinical trials, shaping protocols, safety reviews, regulatory submissions, and study execution across Japan and Asia-Pacific.
Leads ELREXFIO marketing strategy and business performance, directing brand plans, forecasting, indication-expansion launches and cross-functional execution with commercial and medical partners.
Leads Pfizer Japan deals across partnerships, licensing, acquisitions and divestitures, from opportunity assessment through negotiation, contracting and post-deal alliance management.
Leads TUKYSA's Japan franchise strategy, business planning and launch execution, managing performance and promotional resources while aligning marketing and cross-functional teams.
Leads real-world evidence studies and large-scale data analysis, developing Japan-relevant evidence for decisions and scientific communication across therapeutic areas.